The Zituvio range of products contain active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and ...

Three makers of Type 2 diabetes drug Metformin announced recalls Friday, the U.S. Food & Drug Administration reported. The reason for the voluntary recalls: the U.S. Food & Drug Administration ...

Glipizide/metformin HCl; 2.5mg/250mg, 2.5mg/500mg, 5mg/500mg; tabs. Adjunct to diet and exercise in type 2 diabetes, as initial therapy or as second-line therapy when response to a sulfonylurea or ...

AstraZeneca and Bristol-Myers Squibb today announced that Xigduo™ (dapagliflozin and metformin hydrochloride in 5mg/850mg and 5mg/1000mg tablets) has been granted Marketing Authorisation by the ...

Whitehouse Station, NJ - Merck announced on February 2, 2012 that the US Food and Drug Administration (FDA) has approved Janumet XR (sitagliptin and extended-release metformin hydrochloride) tablets ...

One of the manufacturers of a Type 2 diabetes drug, Metformin Hydrochloride Extended-Release Tablets, extended its recall of its 500mg and 750 mg pills, the U.S. Food and Drug Administration reported ...

(CNN) -- A widely-used diabetes drug has been recalled after manufacturers found it contained unacceptably high levels of a cancer-causing contaminant. Indian pharmaceutical company Marksans Pharma ...

WESTON, Fla., June 5, 2020 /PRNewswire/ - Apotex is expanding the previously announced Retail Level recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg that was initiated on May 29, ...

Dublin, March 30, 2020 (GLOBE NEWSWIRE) -- The "Metformin Hydrochloride (CAS 1115-70-4) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering. This global report is a ...

Metformin is one of the most commonly used drugs in the treatment of diabetes type 2. It is a biguanide. This application note describes the assay of metformin hydrochloride in compliance with USP ...